Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$10M Sell
92,802
-17,529
-16% -$1.87M 1.14% 17
2020
Q4
$11.8M Sell
110,331
-2,091
-2% -$201K 1.25% 15
2020
Q3
$9.85M Sell
112,422
-7,215
-6% -$679K 1.17% 18
2020
Q2
$8.7M Buy
119,637
+3,613
+3% +$318K 0.99% 25
2020
Q1
$8.84M Sell
116,024
-569
-0.5% -$48.5K 1.31% 18
2019
Q4
$10.3M Buy
116,593
+595
+0.5% +$49.4K 1.17% 19
2019
Q3
$8.78M Buy
+115,998
New +$7.95M 1.06% 24

Other funds holding ABBV

TCF National Bank's ABBV Position: Q1 2021 in Review

TCF National Bank reduced its AbbVie (ABBV) stake by 16% in Q1 2021, selling an estimated $1.87M and leaving 92,802 shares worth $10M. The position accounts for 1.14% of the portfolio, ranked #17.

TCF National Bank first reported a position in ABBV in Q3 2019 and has held it in 7 quarters since. The position peaked at $11.8M in Q4 2020. 2,614 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

  • TCF National Bank held 92,802 shares of AbbVie worth $10M as of Q1 2021.
  • TCF National Bank sold 17,529 AbbVie shares in Q1 2021, an estimated $1.87M.
  • AbbVie made up 1.14% of TCF National Bank's portfolio in Q1 2021, its #17 holding.
  • TCF National Bank first reported a position in AbbVie in Q3 2019 and has held it in 7 quarters since.
  • TCF National Bank's AbbVie position peaked at $11.8M in Q4 2020.
  • 2,614 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on TCF National Bank's 13F filing for Q1 2021, filed 30 Apr 2021.